Gilead CEO on treating Covid-19: 'We're not finished with remdesivir'

Daniel O'Day, Gilead chairman and CEO, joins "Squawk Box" to discuss the company's continuing efforts to treat coronavirus patients with remdesivir, a drug that has previously been used to treat Ebola.
03:40
Mon, Sep 14 20207:28 AM EDT